Clinical Trials Directive
This article was originally published in RAJ Devices
Amended Huriet-Serusclat law issued for comment
You may also be interested in...
Officials explain how remote record reviews, site transfers and other factors can green-light approvals of drugs and biologics.
The pandemic is expected to dominate the industry's second quarter earnings calls, which kick off on 16 July, but here are 10 other topics to listen for.
The efforts to upgrade FDA’s information technology infrastructure may be opening up into an opportunity to reinvent its processes for regulatory decision making.